Cutoffs for serum mold-specific IgG levels for hypersensitivity pneumonitis: a diagnostic test accuracy study of 219 subjects

Sahajal Dhooria; Ritesh Agarwal; Inderpaul Singh Sehgal; Valliappan Muthu; Kuruswamy Thurai Prasad; Shivaprakash M Rudramurthy; Nalini Gupta; Amanjit Bal; Mani Singh Meho; Mandeep Kaur Sadhra; Mandeep Garg; Ashutosh Nath Aggarwal

doi:10.36141/svdld.2026.18031

Authors

Sahajal Dhooria Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Ritesh Agarwal Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Inderpaul Singh Sehgal Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Valliappan Muthu Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Kuruswamy Thurai Prasad Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Shivaprakash M Rudramurthy Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Nalini Gupta Department of Cytology and Gynecologic Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Amanjit Bal Department of Histopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Mani Singh Meho Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Mandeep Kaur Sadhra Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Mandeep Garg Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Ashutosh Nath Aggarwal Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

Keywords:

hypersensitivity pneumonitis, interstitial lung disease, sarcoidosis, molds, exposure, biomarker, precipitins, idiopathic pulmonary fibrosis

Abstract

Background: American Thoracic Society guidelines suggest serum specific IgG (sIgG) testing targeting potential antigens associated with hypersensitivity pneumonitis (HP). The diagnostic cutoffs of mold-sIgGs remain undefined and their performance based on pre- and post-test probabilities remain untested.

Methods: We conducted a diagnostic test accuracy study using a case-control design. We enrolled subjects with HP (cases), other interstitial lung diseases (ILDs, diseased controls), and healthy controls with/without mold exposure. We measured sIgG against Aspergillus fumigatus, Penicillium chrysogenum, Cladosporium herbarum, and Micropolyspora faeni using an automated, fluorescent enzyme immunoassay. Cutoffs were derived from the 95^th percentile values among non-exposed healthy controls for individual sIgGs and Youden’s J-statistic for pooled sIgG (sum of four levels). We evaluated the performance characteristics of sIgG levels for HP diagnosis among subjects with ILDs.

Results: We included 219 subjects (mean age, 51.4 years; 50.2% women): 105 HP, 64 non-HP ILDs, and 50 healthy controls (25 non-exposed, 25 exposed). Cutoffs (mgA/L) were 33, 22, 34, 8, and 53, for A. fumigatus, P. chrysogenum, C. herbarum, M. faeni, and pooled sIgG levels, respectively. The 4-mold panel (positive if any sIgG exceeded cutoff) showed 57.1% sensitivity and 78.1% specificity for HP diagnosis among ILD subjects. The pooled sIgG test (positive likelihood ratio, 3.29; negative likelihood ratio, 0.51) shifted post-test probability of HP diagnosis from 44% (for a negative test) to 84% (for a positive test).

Conclusion: Mold-specific IgGs, when used at our proposed cutoffs, significantly alter post-test diagnostic probabilities; thus, can be used as an adjunct in multi-component HP diagnosis.

Author Biography

Inderpaul Singh Sehgal, Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

`

References

1. Barnes H, Troy L, Lee CT, Sperling A, Strek M, Glaspole I. Hypersensitivity pneumonitis: current concepts in pathogenesis, diagnosis, and treatment. Allergy. 2022;77:442-53.

2. Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202:e36-69.

3. Hamblin M, Prosch H, Vašáková M. Diagnosis, course and management of hypersensitivity pneumonitis. Eur Respir Rev. 2022;31.

4. Mitra S, Dhooria S, Agarwal R, Das A, Garg M, Bal A. Histopathological spectrum of hypersensitivity pneumonitis with clinico-radiologic correlation. Apmis. 2019;127:616-26.

5. Gomes ML, Morais A, Cavaleiro Rufo J. The association between fungi exposure and hypersensitivity pneumonitis: a systematic review. Porto Biomed J. 2021;6:e117.

6. Petnak T, Moua T. Exposure assessment in hypersensitivity pneumonitis: a comprehensive review and proposed screening questionnaire. ERJ Open Res. 2020;6.

7. Jenkins AR, Chua A, Chami H, et al. Questionnaires or serum immunoglobulin G testing in the diagnosis of hypersensitivity pneumonitis among patients with interstitial lung disease. Ann Am Thorac Soc. 2021;18:130-47.

8. Barnes H, Chambers D, Grainge C, et al. Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire. Respirology. 2023;28:366-72.

9. Johannson KA, Barnes H, Bellanger AP, et al. Exposure assessment tools for hypersensitivity pneumonitis. An official American Thoracic Society workshop report. Ann Am Thorac Soc. 2020;17:1501-9.

10. Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem. 2015;61:1446-52.

11. Richerson HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol. 1989;84:839-44.

12. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-55.

13. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 Suppl 5:v1-58.

14. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824.

15. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733-48.

16. Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44-68.

17. Singh S, Sharma BB, Bairwa M, et al. Management of interstitial lung diseases: a consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP). Lung India. 2020;37:359-78.

18. Dhooria S, Agarwal R, Sehgal IS, et al. Spectrum of interstitial lung diseases at a tertiary center in a developing country: a study of 803 subjects. PLoS One. 2018;13:e0191938.

19. Dhooria S, Sehgal IS, Agarwal R, et al. Incidence, prevalence, and national burden of interstitial lung diseases in India: estimates from two studies of 3089 subjects. PLoS One. 2022;17:e0271665.

20. Dhooria S. Idiopathic nonspecific interstitial pneumonia: waters remain murky…remember ABCDEFGHI. Lung India. 2024;41:169-71.

21. Barnes H, Morisset J, Molyneaux P, Westall G, Glaspole I, Collard HR. A systematically derived exposure assessment instrument for chronic hypersensitivity pneumonitis. Chest. 2020;157:1506-12.

22. Samson MH, Vestergaard JM, Knudsen CS, Kolstad HA. Serum levels of IgG antibodies against Aspergillus fumigatus and the risk of hypersensitivity pneumonitis and other interstitial lung diseases. Scand J Clin Lab Invest. 2021;81:451-3.

23. Demirkol B, Satici C, Tanriverdi E, et al. Serum specific antibodies do not seem to have an additional role in the diagnosis of hypersensitivity pneumonitis. Med Lav. 2023;114:e2023042.

24. Rautalahti M, Terho EO, Ojanen T. Changes in the titers of IgG antibodies against farmer's lung antigens in the sera of healthy dairy farmers. Ann Allergy. 1990;64:455-8.

25. Kurup VP, Mäntyjärvi RA, Terho EO, Ojanen TH, Kalbfleisch JH. Circulating IgG antibodies against fungal and actinomycete antigens in the sera of farmer's lung patients from different countries. Mycopathologia. 1987;98:91-9.

26. Boyd G, Parratt D. Improved diagnosis of farmer's lung using the fluorescent antibody technique. Thorax. 1974;29:417-20.

27. doPico GA, Reddan WG, Chmelik F, Peters ME, Reed CE, Rankin J. The value of precipitating antibodies in screening for hypersensitivity pneumonitis. Am Rev Respir Dis. 1976;113:451-5.

28. Gruchow HW, Hoffmann RG, Marx JJ Jr, et al. Precipitating antibodies to farmer's lung antigens in a Wisconsin farming population. Am Rev Respir Dis. 1981;124:411-5.

29. Marx JJ Jr, Gray RL. Comparison of the enzyme-linked immunosorbent assay and double immunodiffusion test for the detection and quantitation of antibodies in farmer's lung disease. J Allergy Clin Immunol. 1982;70:109-13.

30. Petnak T, Thongprayoon C, Baqir M, Ryu JH, Moua T. Antigen identification and avoidance on outcomes in fibrotic hypersensitivity pneumonitis. Eur Respir J. 2022;60.

31. Sehgal IS, Choudhary H, Dhooria S, et al. Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis. Mycoses. 2018;61:770-6.

32. Sehgal IS, Dhooria S, Prasad KT, et al. Comparative diagnostic accuracy of immunoprecipitation versus immunoassay methods for detecting Aspergillus fumigatus-specific IgG in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis. Mycoses. 2022;65:866-76.

33. Ryerson CJ, Adegunsoye A, Piciucchi S, et al. Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement. Eur Respir J. 2025;66:2500158.

34. Muthu V, Sehgal IS, Dhooria S, et al. Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: a systematic review and diagnostic test accuracy meta-analysis. Clin Exp Allergy. 2018;48:1107-36.